Skip to main content

Peer Review reports

From: Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated 18F–Fluorodeoxyglucose (18F–FDG) positron emission tomography/magnetic resonance imaging (PET/MRI); The REMAP study

Original Submission
19 Dec 2016 Submitted Original manuscript
27 Jan 2017 Author responded Author comments - Christian Kelly-Morland
Resubmission - Version 2
27 Jan 2017 Submitted Manuscript version 2
17 May 2017 Editorially accepted
2 Jun 2017 Article published 10.1186/s12885-017-3371-9

You can find further information about peer review here.

Back to article page